Last reviewed 2026-04-23 · How we verify

Placebo of D064 and D702, QD

Chong Kun Dang Pharmaceutical · Phase 3 active Small molecule

Placebo of D064 and D702, QD is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 3 development. Also known as: D702 Monotherapy.

This is a placebo control arm and contains no active pharmaceutical ingredient.

At a glance

Generic name	Placebo of D064 and D702, QD
Also known as	D702 Monotherapy
Sponsor	Chong Kun Dang Pharmaceutical
Modality	Small molecule
Phase	Phase 3

Mechanism of action

Placebo formulations are inert substances used as control comparators in clinical trials to establish the efficacy of active drugs through blinded comparison. In this Phase 3 trial, the placebo serves as the control arm against which D064 and D702 (the active investigational drugs) are being evaluated. No mechanistic activity is expected from the placebo itself.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Placebo of D064 and D702, QD CI brief — competitive landscape report
Placebo of D064 and D702, QD updates RSS · CI watch RSS
Chong Kun Dang Pharmaceutical portfolio CI

Frequently asked questions about Placebo of D064 and D702, QD

What is Placebo of D064 and D702, QD?

Placebo of D064 and D702, QD is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.

How does Placebo of D064 and D702, QD work?

This is a placebo control arm and contains no active pharmaceutical ingredient.

Who makes Placebo of D064 and D702, QD?

Placebo of D064 and D702, QD is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).

Is Placebo of D064 and D702, QD also known as anything else?

Placebo of D064 and D702, QD is also known as D702 Monotherapy.

What development phase is Placebo of D064 and D702, QD in?

Placebo of D064 and D702, QD is in Phase 3.

Manufacturer: Chong Kun Dang Pharmaceutical — full pipeline
Also known as: D702 Monotherapy
Compare: Placebo of D064 and D702, QD vs similar drugs
Pricing: Placebo of D064 and D702, QD cost, discount & access